Recent advances in hydrogels for cartilage tissue engineering.

Articular cartilage is a load-bearing tissue that lines the surface of bones in diarthrodial joints. Unfortunately, this avascular tissue has a limited capacity for intrinsic repair. Treatment options for articular cartilage defects include microfracture and arthroplasty; however, these strategies fail to generate tissue that adequately restores damaged cartilage. Limitations of current treatments for cartilage defects have prompted the field of cartilage tissue engineering, which seeks to integrate engineering and biological principles to promote the growth of new cartilage to replace damaged tissue. To date, a wide range of scaffolds and cell sources have emerged with a focus on recapitulating the microenvironments present during development or in adult tissue, in order to induce the formation of cartilaginous constructs with biochemical and mechanical properties of native tissue. Hydrogels have emerged as a promising scaffold due to the wide range of possible properties and the ability to entrap cells within the material. Towards improving cartilage repair, hydrogel design has advanced in recent years to improve their utility. Some of these advances include the development of improved network crosslinking (e.g. double-networks), new techniques to process hydrogels (e.g. 3D printing) and better incorporation of biological signals (e.g. controlled release). This review summarises these innovative approaches to engineer hydrogels towards cartilage repair, with an eye towards eventual clinical translation.

[Normal ventilatory response to hypoxia and hypercapnia at an altitude of 2240 meters]. / Respuesta ventilatoria normal a hipoxia e hipercapnia a una altitud de 2240 metros.

OBJECTIVE: To evaluate the ventilatory response to hypoxia and hypercapnia in healthy residents of Mexico City at 2240 m above sea level. METHODS: 15 healthy subjects, 10 women and 5 men, were studied (mean age 38; range 26-76). All completed one or two tests of ventilatory response to hypoxia and hypercapnia as described by Rebuck-Campbell and Read, respectively. The results were analyzed by linear regression using the minute ventilation as the dependent variable and SaO2 (hypoxia) or PCO2 (hypercapnia) as the independent variables. RESULTS: Seven subjects had very low or no response to hypoxia. The mean hypoxia slope was 0.7 +/- 0.6 L/min/% (+/- SD) and the hypercapnia slope was 3.0 +/- 1.4 L/min/mmHg. The intercepts were 176 +/- 278 for SaO2 and 3.0 +/- 7 for PCO2. CONCLUSIONS: A low respiratory response to hypoxia was found in Mexico City Healthy residents. The response to hypercapnia was similar in slope to other studies but had an intercept shifted to lower values. The Mexico City residents showed a behavior typical of patients with chronic hypoxemia or of dwellers at high altitudes.

Experience of an intravenous therapy team at the Instituto Nacional de Cancerología (Mexico) with a long-lasting, low-cost silastic venous catheter.

Means of vascular access are fundamental in the management of cancer. However, since current intravenous devices for long-term treatment are expensive and necessitate a high degree of education among medical personnel, in developing countries they are impractical for use in most of the population. We describe the use of a nontunneled, low-cost, long-lasting Silastic catheter (LLSC), cared for by an intravenous therapy team (IVTT), in 462 patients with cancer. The rate of infectious complications was 0.66 infections per 1,000 catheter-days, which is as low as that reported in association with other catheters in developed countries. Neutropenia and skin and/or soft-tissue infections were significant risk factors associated with LLSC-related infections. We believe that use of this catheter may be an alternative for patients with cancer who need chemotherapy, as long as an IVTT is established for its care. Our experience could be useful for practitioners in countries with similar socioeconomic characteristics.